188 related articles for article (PubMed ID: 32723398)
1. Stem cell membrane-coated isotretinoin for acne treatment.
Wang S; Jiang R; Meng T; Zhang F; Li J; Jin Y; Lee J; Zhu M; Jiang J
J Nanobiotechnology; 2020 Jul; 18(1):106. PubMed ID: 32723398
[TBL] [Abstract][Full Text] [Related]
2. Colloidal carriers of isotretinoin for topical acne treatment: skin uptake, ATR-FTIR and in vitro cytotoxicity studies.
Gürbüz A; Özhan G; Güngör S; Erdal MS
Arch Dermatol Res; 2015 Sep; 307(7):607-15. PubMed ID: 25903443
[TBL] [Abstract][Full Text] [Related]
3. Heat Enhanced Follicular Delivery of Isotretinoin to the Skin.
Farah HA; Brown MB; McAuley WJ
Pharm Res; 2019 Jun; 36(8):124. PubMed ID: 31227928
[TBL] [Abstract][Full Text] [Related]
4. Isotretinoin and α-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne.
Gupta S; Wairkar S; Bhatt LK
J Microencapsul; 2020 Dec; 37(8):557-565. PubMed ID: 32924680
[TBL] [Abstract][Full Text] [Related]
5. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling.
Raza K; Singh B; Singla S; Wadhwa S; Garg B; Chhibber S; Katare OP
Mol Pharm; 2013 May; 10(5):1958-63. PubMed ID: 23544848
[TBL] [Abstract][Full Text] [Related]
6. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Bianchi L
G Ital Dermatol Venereol; 2018 Apr; 153(2):161-164. PubMed ID: 29564872
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
8. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris.
El Aziz Ragab MA; Omar SS; Collier A; El-Wafa RAHA; Gomaa N
Dermatol Ther; 2018 Nov; 31(6):e12715. PubMed ID: 30397984
[TBL] [Abstract][Full Text] [Related]
9. Improved photostability, reduced skin permeation and irritation of isotretinoin by solid lipid nanoparticles.
Shiva G; Somaye M; Reza JM
Acta Pharm; 2012 Dec; 62(4):547-62. PubMed ID: 23333889
[TBL] [Abstract][Full Text] [Related]
10. Low dose isotretinoin combined with tretinoin is effective to correct abnormalities of acne.
Plewig G; Dressel H; Pfleger M; Michelsen S; Kligman AM
J Dtsch Dermatol Ges; 2004 Jan; 2(1):31-45. PubMed ID: 16281880
[TBL] [Abstract][Full Text] [Related]
11. A practical approach for the use of oral isotretinoin for infantile acne.
Barnes CJ; Eichenfield LF; Lee J; Cunningham BB
Pediatr Dermatol; 2005; 22(2):166-9. PubMed ID: 15804310
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
Liu J; Hu W; Chen H; Ni Q; Xu H; Yang X
Int J Pharm; 2007 Jan; 328(2):191-5. PubMed ID: 16978810
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin treatment reduces acne lesions but not directly lesional acne inflammation.
Kelhälä HL; Fyhrquist N; Palatsi R; Lehtimäki S; Väyrynen JP; Kubin ME; Kallioinen M; Alenius H; Tasanen K; Lauerma A
Exp Dermatol; 2016 Jun; 25(6):477-8. PubMed ID: 26845242
[No Abstract] [Full Text] [Related]
14. Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.
Del Rosso JQ
J Drugs Dermatol; 2013 Jun; 12(6):626-31. PubMed ID: 23839177
[TBL] [Abstract][Full Text] [Related]
15. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients.
Fabbrocini G; Cameli N; Lorenzi S; De Padova MP; Marasca C; Izzo R; Monfrecola G
G Ital Dermatol Venereol; 2014 Aug; 149(4):441-5. PubMed ID: 25068233
[TBL] [Abstract][Full Text] [Related]
16. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne.
Raza K; Singh B; Singal P; Wadhwa S; Katare OP
Colloids Surf B Biointerfaces; 2013 May; 105():67-74. PubMed ID: 23357735
[TBL] [Abstract][Full Text] [Related]
17. ARTICLE: Advances in Oral Isotretinoin Therapy.
Jones M; Armstrong AW; Baldwin H; Stein Gold L; Kircik LH
J Drugs Dermatol; 2021 May; 20(5):s5-s11. PubMed ID: 33938693
[TBL] [Abstract][Full Text] [Related]
18. The relevance of nanotechnology, hepato-protective agents in reducing the toxicity and augmenting the bioavailability of isotretinoin.
Hosny KM; Alhakamy NA; Al Nahyah KS
Drug Deliv; 2021 Dec; 28(1):123-133. PubMed ID: 33355019
[TBL] [Abstract][Full Text] [Related]
19. Low dose isotretinoin for pigmented post-varicella scars.
Dave DD; Abdelmaksoud A
Dermatol Ther; 2019 Jan; 32(1):e12768. PubMed ID: 30296353
[No Abstract] [Full Text] [Related]
20. ABSORICA (isotretinoin): a new form.
Scheinfeld N
Skinmed; 2013; 11(2):117-9. PubMed ID: 23745231
[No Abstract] [Full Text] [Related]
[Next] [New Search]
